Traditional Chinese medicine composition for treating liver cirrhosis

Abstract

The invention discloses traditional Chinese medicine composition for treating liver cirrhosis. The composition comprises raw materials in parts by weight as follows: 10-15 parts of pilose asiabell roots, 16-22 parts of bighead atractylodes rhizome, 12-18 parts of curcuma aromatica, 10-15 parts of artemisia capillaris, 8-14 parts of Chinese lobelia herbs, 5-10 parts of tamariskoid spikemoss herbs, 10-15 parts of rhizoma atractylodis, 6-12 parts of rush pith, 9-16 parts of radix bupleuri, 10-15 parts of common burreed rhizome, 5-10 parts of curcuma zedoary, 15-20 parts of Danshen roots, 17-23 parts of common peony roots, 10-15 parts of gynura formosana, 12-18 parts of herba lycopi, 7-13 parts of fructus aurantii, 5-10 parts of coix seeds, 10-15 parts of angelica keiskei, 10-15 parts of astragalus membranaceus, 5-10 parts of rhizoma corydalis, 12-18 parts of turtle shells, 16-22 parts of pangolin scales, 10-15 parts of nutmeg, 5-10 parts of agilawood, 15-20 parts of nutgrass galingale rhizome, 10-15 parts of green tangerine peel and 5-10 parts of milk thistle. The traditional Chinese medicine composition has functions of liver and kidney nourishing, qi circulation promoting, diuresis inducing, blood stasis dispersing, pain relieving, liver soothing, qi flowing regulating, spleen strengthening and food retention removing and is good in liver cirrhosis treatment effect, definite and fast in efficacy, short in treatment course, high in cure rate, free from toxic and side effects and worthy of popularization and application.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating liver cirrhosis. Background technique [0002] Liver cirrhosis is a chronic diffuse liver disease that can be caused by various diseases. Due to various reasons, after the liver cells are destroyed, they cannot be repaired, forming fatty infiltration and fibrous tissue hyperplasia, resulting in liver cirrhosis. The early manifestations are similar to those of chronic hepatitis. If it is not treated in time, it may develop into hepatosplenomegaly, ascites, or even hematemesis and coma. The traditional Chinese medicines currently used to treat liver cirrhosis still have insufficient curative effect and relatively slow effect, so that a large number of patients with liver cirrhosis continue to aggravate liver fibrosis, and finally cause gastrointestinal bleeding and hepatic encephalopathy [0003] Death from compl...

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problem that the effect of the existing traditional Chinese medicine is not obvious enough and the effect is relatively slow, the purpose of the present invention is to provide a Chinese medicine composition for treating liver cirrhosis with exact drug effect, remarkable curative effect and quick effect